GenSight Biologics Market Cap

GenSight Biologics has a market cap or net worth of €35.99 million as of November 21, 2024. Its market cap has increased by 30.18% in one year.

Market Cap

35.99M

Enterprise Value

51.73M

Revenue

1.98M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.32

Market Cap Chart

Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 35.99M, a decrease of -85.73%. That is a compound annual growth rate of -20.77%.

Market Cap History

Date	Market Cap	% Change
Nov 20, 2024	35.99M	40.22%
Dec 29, 2023	25.66M	-83.46%
Dec 30, 2022	155.20M	-39.23%
Dec 31, 2021	255.38M	-16.09%
Dec 31, 2020	304.35M	275.09%
Dec 31, 2019	81.14M	-1.47%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sanofi	114.34B
EssilorLuxottica Société anonyme	106.74B
Sartorius Stedim Biotech S.A.	16.33B
bioMérieux S.A.	11.56B
Ipsen S.A.	8.81B
Eurofins Scientific SE	8.62B
Virbac SA	2.68B
Ramsay Générale de Santé SA	1.32B

Market Cap Rankings